We are live on
!
Find out more
GP
GLG Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
21.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
(+13%)
Cap. Flow
-$130M
Cap. Flow
% of AUM
-6.09%
Top 10 Holdings %
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AAAP
Advanced Accelerator Applications S.A.
AAAP
|
+$46.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$35M |
| 3 |
MON
Monsanto Co
MON
|
+$29.2M |
| 4 |
CYOU
Changyou.com Limited American Depositary Share
CYOU
|
+$22.9M |
| 5 |
Dell
DELL
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
+$29M |
| 2 |
RICE
Rice Energy Inc.
RICE
|
+$23M |
| 3 |
Criteo S.A.
CRTO
|
+$22.5M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$18M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.22% |
| 2 | Consumer Discretionary | 13.47% |
| 3 | Technology | 9.7% |
| 4 | Financials | 9.51% |
| 5 | Industrials | 8.72% |
Similar funds
IH
GL
TAM
SI
GES
AS
QAM
BTIS
GLG Partners's Q4 2017 Portfolio in Review
As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals Inc, an estimated $29M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.
- GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
- GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
- GLG Partners's biggest Q4 2017 reduction was Criteo S.A., cutting an estimated $22.5M.
- GLG Partners fully exited Sciclone Pharmaceuticals Inc in Q4 2017, selling an estimated $29M.
- GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
- GLG Partners opened 243 new positions and closed 91 in Q4 2017.
- GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.
Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.